iBio, Inc. (IBIO) Financials
IBIO Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 34.0 million | 24.8 million |
2023-09-30 | 37.7 million | 24.5 million |
2023-06-30 | 41.2 million | 25.8 million |
2023-03-31 | 44.4 million | 27.0 million |
IBIO Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -4.7 million | 456000 |
2023-09-30 | -5.3 million | 765000 |
2023-06-30 | -5.5 million | 446000 |
2023-03-31 | -3.7 million | 1.6 million |
IBIO Net Income
No data available :(
IBIO Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 2.8 million | - | 3.8 million |
2023-09-30 | 1.5 million | - | 4.0 million |
2023-06-30 | 4.3 million | - | 4.1 million |
2023-03-31 | 6.6 million | - | 4.3 million |
IBIO Shares Outstanding
IBIO Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | 1.5 million | 3.0 million | - |
2023-09-30 | - | 1.6 million | 3.5 million | - |
2023-06-30 | 506000 | 2.4 million | 2.6 million | - |
2023-03-31 | 201000 | 2.6 million | 3.5 million | - |
IBIO Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | 387000 |
2023-09-30 | 50000 | 250000 |
2023-06-30 | - | 31000 |
2023-03-31 | - | 282000 |
IBIO
Price: $1.76
52 week price:
Earnings Per Share: -15.25 USD
P/E Ratio: -0.03
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Volume: 1.7 million
Market Capitalization: 7.2 million